Develop, Protect And Unlock True Value

In today’s business world, your Intellectual Property (IP) is a critical competitive advantage that you have to actively manage, protect and leverage.

As an IP owner or manager you are constantly looking for intelligence and answers to help you get more out of your intellectual property. At Aranca, we understand the challenges faced by you and have customized solutions that help you to manage, protect and drive value of your IP assets across the IP lifecycle.

Our Technology Intelligence & IP Research team delivers tailored solutions covering technology landscape studies, whitespace analysis, patent analytics, prior art searches, patent drafting and research, IP valuation, out-licensing support and litigation support. This doubled with the expertise of our Business Research & Advisory and Valuation Advisory teams help us bring together perspectives that are normally missed by other service providers in this space, when answering key questions to enable your IP strategy decisions.

A trusted partner to 300+ global companies, including


Fortune 500 Companies


Technology Consulting Firms


Law Firms

Business research partner for Fortune500 firms


Universities & Research Institutes

Solutions Portfolio


Technology Intelligence

Drive business value and competitive advantage with well-defined R&D and technology strategies.

Learn More


IP Strategy

Maximize value of your IP investments across the patent lifecycle, from protection to monetization.

Learn More


Litigation Support

Are you armed with the right technical evidence when it comes to patent litigation?

Learn More

Why Aranca?


Engage With Specialists

Leverage analysts with advanced degrees and deep knowledge your technology domain.


Proprietary Frameworks

Leverage our methodologies to solve complex tech and IP related strategic questions.


Experience Matters

10,000+ projects executed, spanning 250 technology domains and all important IP jurisdictions.


Expert Network Access

We combine internal expertise with the opinions of 10,000+ technology experts to generate insights that matter.


Deep Market Knowledge

Leverage our market intelligence capabilities to strengthen your technology & IP strategies.


Customized Solutions,

We design tailor-made solutions for each client request that address specific issues and budgets.

Proprietary Frameworks

Benefit from our unique methodologies to answer complex technical and IP related questions.


Patent Quality Index

Framework to assess the quality of patents in a portfolio through a combination of subjective and objective parameters.


Tech Attractiveness

Benchmarking tool to assess technology attractiveness based on technical/market and commercialization potential.


Innovation Maps

Framework for analysis and visual representation of large volumes of scientific information using predefined algorithms.


Patent Valuation

A robust methodology for valuing patents based on quality/market dynamics and earning attributable to the technical know-how.

Looking for help with Technology Intelligence, IP Strategy, or Litigation support?

Knowledge Library

  1. 1
  2. 2
  3. 3
  1. 2
  2. 3
  1. Evolution of Powered Exoskeletons

    Envisaged over a hundred years ago as a steam-powered set of locomotive legs, we’ve come a long way in our quest to seriously suit-up.

  2. 2
  3. CRISPR/Cas9 – Market Players Snapshot

    We're entering a new era in molecular biology. A new tool based on a bacterial CRISPR-associated protein-9 nuclease (Cas9) from Streptococcus pyogenes will enable the

  4. 3
  1. How to Get the Most Out of IP Financing

    The use of intellectual property as collateral to obtain finance is an increasingly common phenomenon. Over the past three decades, the proportion of tangible assets

  2. 2
  3. The Internet of Medical Things (IoMT)

    A healthcare application of IoT technologies, the concept of Internet of Medical Things (IoMT) envisions a network of connected devices that sense vital data in

  4. 3
  5. Cardiac Nuclear Imaging and Radiotracers

    Recent novel radiopharmaceuticals agents developed to target specific subcellular process are capable of significantly improving diagnostic accuracy and prognostic evaluation. The global nuclear medicine diagnostic